Compare NVTS & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVTS | QDEL |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | NVTS | QDEL |
|---|---|---|
| Price | $7.36 | $28.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | $5.92 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 17.5M | 1.1M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $56,598,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.52 | $19.50 |
| 52 Week High | $17.79 | $49.45 |
| Indicator | NVTS | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 36.41 | 56.06 |
| Support Level | $8.01 | $28.22 |
| Resistance Level | $10.24 | $30.40 |
| Average True Range (ATR) | 0.67 | 1.20 |
| MACD | -0.10 | 0.18 |
| Stochastic Oscillator | 0.00 | 51.15 |
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.